abstract |
The invention relates to a method for the simplified isolation in high yields of sponge collagen, especially from marine sponges, and to the production of collagen nanoparticles from collagen. The invention further relates to the use thereof for influencing cell-dependent processes in vitro and in vivo, especially when orally or topically administered to treat inflammatory, preferably cyclooxygenase-dependent diseases. |